US Stock MarketDetailed Quotes

VNDA Vanda Pharmaceuticals

Watchlist
  • 4.610
  • -0.010-0.22%
Close Dec 13 16:00 ET
  • 4.640
  • +0.030+0.64%
Post 20:01 ET
268.80MMarket Cap-15.90P/E (TTM)

About Vanda Pharmaceuticals Company

Vanda Pharmaceuticals, Inc. engages in the development and commercialization of therapies for high unmet medical needs. The firm intends to treat schizophrenia, jet lag disorder, atopic dermatitis, central nervous system disorders, and circadian rhythm sleep disorder. Its product portfolio includes HETLIOZ, Fanapt, Tradipitant, Trichostatin, and AQW051. The company was founded by Mihael Hristos Polymeropoulos and Argeris N. Karabelas in 2002 and is headquartered in Washington, DC.

Company Profile

SymbolVNDA
Company NameVanda Pharmaceuticals
Listing DateApr 12, 2006
Issue Price10.00
Founded2002
CEODr. Mihael Hristos Polymeropoulos,M.D.
MarketNASDAQ
Employees203
Fiscal Year Ends12-31
Address2200 Pennsylvania Avenue NW,Suite 300E
CityWashington
ProvinceDistrict of Columbia
CountryUnited States of America
Zip Code20037
Phone1-202-734-3400
Websitehttp://www.vandapharma.com

Company Executives

  • Name
  • Position
  • Salary
  • Dr. Mihael Hristos Polymeropoulos,M.D.
  • Chairman of the Board, President and Chief Executive Officer
  • 3.72M
  • Joakim Wijkstrom
  • Senior Vice President and Chief Marketing Officer
  • 1.36M
  • Kevin Moran
  • Senior Vice President, Principal Accounting Officer, Chief Financial Officer and Treasurer
  • 1.32M
  • Timothy Williams
  • Senior Vice President, General Counsel and Secretary
  • 1.40M
  • Gunther Birznieks
  • Senior Vice President, Business Development
  • 1.37M
  • Stephen Ray Mitchell
  • Independent Director
  • 282.50K
  • Anne Sempowski Ward
  • Independent Director
  • 302.50K
  • Tage Honore
  • Independent Director
  • 602.43K
  • Phaedra Chrousos
  • Independent Director
  • 300.00K
  • Richard W. Dugan
  • Lead Independent Director
  • 332.50K
Heat List
US
Overall
Symbol
Price
% Chg

No Data